Abstract:Purpose Statins may have a protective effect against osteoarthritis (including knee osteoarthritis and hip osteoarthritis); however, the link between statins and osteoarthritis risk is incompletely established. The aim of this study was to explore the relationship between statins and osteoarthritis risk through Mendelian randomization analysis using pooled information from a large population-wide genome-wide association study (GWAS). Methods Statin-related single-nucleotide polymorphisms (SNPs) were obtained from FinnGen’s latest 9th edition database, and data on osteoarthritis, knee osteoarthritis, and hip osteoarthritis were acquired from the IEU OpenGWAS, the UK Biobank, and Arthritis Research UK Osteoarthritis Genetics (ArcOGEN) database, respectively. The inverse-variance weighting method is an important analysis method to estimate the causal effect. Weighted median method, simple median method, weighted median estimator method, and MR–Egger regression were employed to supplement the explanation. Odds ratio and 95%CI were used to evaluate the causal relationship among statins and the osteoarthritis risk, osteoarthritis in the knee, and osteoarthritis in the hip. Second, sensitivity analysis was carried out to validate the reliability of the results. Cochran’s Q test was employed to test heterogeneity, MR–Egger intercept was employed to test whether horizontal pleiotropy existed, and single-nucleotide polymorphisms with potential influence were determined by the one-method analysis. Results (1) The results of the inverse variance weighting method showed Gene prediction indicated that statins were associated with osteoarthritis (OR = 0.998, 95% CI: 0.996–0.999, P = 0.01) and knee osteoarthritis (OR = 0.964, 95% CI: knee (0.940–0.989, P = 0.005) and hip osteoarthritis risk were associated (OR = 0.928, 95% CI: 0.901–0.955, P = 4.28 × 10 −7 ). (2) MR–Egger intercept analysis did not detect potential horizontal pleiotropy (osteoarthritis: P = 0.658; knee osteoarthritis: P = 0.600; and hip osteoarthritis: P = 0.141). (3) The findings provide evidence that statins reduce osteoarthritis risk, osteoarthritis in the knee, and osteoarthritis in the hip, as described in observational studies, and the specific mechanisms by which statins treat osteoarthritis require further investigation. Conclusion The results of this study, at the genetic level, reveal a negative causal relationship between statins and osteoarthritis, and this causal relationship is also present in knee and hip osteoarthritis. This study provides evidence against the potential of statins in the treatment of osteoarthritis, prompting the clinical treatment of osteoarthritis to consider improving the start and compliance of statins in the future.

Effect of blood lipids and lipid-lowering therapies on osteoarthritis risk: A Mendelian randomization study

Causal Associations of Circulating Lipids with Osteoarthritis: A Bidirectional Mendelian Randomization Study

Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study

Potential benefits of statin therapy in reducing osteoarthritis risk: a Mendelian randomization study

The association between lipid biomarkers and osteoarthritis based on the National Health and Nutrition Examination Survey and Mendelian randomization study

Associations Between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study

Exploring the causal link among statin drugs and the osteoarthritis risk based on Mendelian randomization research

Assessing the causal associations of different types of statins use and knee/hip osteoarthritis: A Mendelian randomization study

Plasma lipids, alcohol intake frequency and risk of Osteoarthritis: a Mendelian randomization study

Osteoarthritis and risk of cardiovascular diseases: A Mendelian randomization study

Causal link between metabolic related factors and osteoarthritis: a Mendelian randomization investigation

Causal impact of statins on susceptibility to osteoarthritis: insights from a two-sample Mendelian randomization analysis

Causal factors for osteoarthritis risk revealed by mendelian randomization analysis

Osteoarthritis and cardiovascular disease: A Mendelian randomization study

Sex Hormone-Binding Globulin and Arthritis: a Mendelian Randomization Study

The effect of systemic iron status on osteoarthritis: A mendelian randomization study

Genetic causal association between lipidomic profiles, inflammatory proteomics, and aortic stenosis: a Mendelian randomization investigation

The Relationship Between Blood Lipids and Risk of Atrial Fibrillation: Univariable and Multivariable Mendelian Randomization Analysis

Causal associations of obesity related anthropometric indicators and body compositions with knee and hip arthritis: A large-scale genetic correlation study

Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study

No genetic causal association between circulating alpha-tocopherol levels and osteoarthritis, a two-sample Mendelian randomization analysis